The gut microbiota, bacterial metabolites and colorectal cancer
This 2014 review explores the role of the gut microbiota and its metabolites in colorectal cancer (CRC) development. It highlights how microbial dysbiosis and the resulting metabolic byproducts can influence carcinogenesis. Beneficial metabolites like short-chain fatty acids (SCFAs) such as butyrate support colon health by reducing inflammation and promoting apoptosis